Search results
Oct 15, 2019 · Vitaccess have been based here at Oxford Centre for Innovation (OCFI) for nearly two years and, during that time, have seen steep growth. Read on and meet Vitaccess’ CEO and founder, Dr Mark Larkin.
Dr Mark Larkin is the founder and CEO of digital healthcare scale-up Vitaccess. He established the company in Oxford in 2017 to offer international real-world evidence (RWE) solutions to the biopharmaceutical market via smartphone apps and data science.
Jun 11, 2021 · For this first edition, Vitaccess’ Founder and CEO Dr Mark Larkin and Senior Consultant Sam Llewellyn talked about real-world evidence in rare disease. Vitaccess is an established partner in real-world evidence in the field of rare diseases, with several studies conducted globally.
Dr Mark Larkin is the Founder of digital healthcare research company Vitaccess (www.vitaccess.com). Mark founded Vitaccess to explore the use of mobile technology in healthcare. He led the development of the Vitaccess digital real-world evidence platform, which uses patients' own mobile devices to quantify the impact of treatments and ...
We are health economists, researchers, eClinical health experts, data scientists, software developers, linguists, and medical writers, all committed to insightful digital research. Get in touch with us.
Feb 20, 2019 · This comes on the back of sustained success during 2018 in which CEO Dr Mark Larkin was named Regulatory Tech Founder of the Year in the BMWi UK Tech Founder Awards. He was also named runner-up in the CIS Technology Excellence Awards in the Oxfordshire Business Awards and shortlisted as Start-Up Entrepreneur of the Year 2018 in the NatWest ...
Mark Larkin talks about patient centricity in creating the Melanoma UK appMelanoma, digital registry, cancer, real world evidence, patient centricity, HEOR, ...
